LV12792B - Formyl- or cyano- substituted indole derivatives having dopaminergic activity - Google Patents
Formyl- or cyano- substituted indole derivatives having dopaminergic activityInfo
- Publication number
- LV12792B LV12792B LVP-01-129A LV010129A LV12792B LV 12792 B LV12792 B LV 12792B LV 010129 A LV010129 A LV 010129A LV 12792 B LV12792 B LV 12792B
- Authority
- LV
- Latvia
- Prior art keywords
- 6alkyl
- dopamine
- independently hydrogen
- formyl
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3756893A | 1993-03-25 | 1993-03-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
LV12792A LV12792A (en) | 2002-02-20 |
LV12792B true LV12792B (en) | 2002-06-20 |
Family
ID=21895045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-01-129A LV12792B (en) | 1993-03-25 | 2001-08-30 | Formyl- or cyano- substituted indole derivatives having dopaminergic activity |
Country Status (13)
Country | Link |
---|---|
US (1) | US5639778A (de) |
EP (1) | EP0690843B1 (de) |
JP (1) | JP3298885B2 (de) |
AT (1) | ATE195935T1 (de) |
AU (1) | AU679053B2 (de) |
DE (1) | DE69425736T2 (de) |
DK (1) | DK0690843T3 (de) |
ES (1) | ES2149869T3 (de) |
GR (1) | GR3034906T3 (de) |
LV (1) | LV12792B (de) |
NZ (1) | NZ263403A (de) |
PT (1) | PT690843E (de) |
WO (1) | WO1994021608A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK282725B6 (sk) * | 1996-05-31 | 2002-11-06 | Pharmacia & Upjohn Company | Arylom substituované cyklické amíny ako selektívne D3 ligandy dopamínu |
FR2763335B1 (fr) * | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
IT1292155B1 (it) * | 1997-06-13 | 1999-01-25 | Zambon Spa | Derivati naftotiazolonici attivi sul recettore dopaminergico d 3 |
EP1349834A2 (de) * | 2000-12-18 | 2003-10-08 | Eli Lilly And Company | Cycloalkyl kondensierte [g]-indol verbindungen als spla2-inhibitoren zur behandlung von entzündungskrankheiten |
AU2002238106A1 (en) * | 2001-02-13 | 2002-08-28 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
AU2002331064B2 (en) * | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7655658B2 (en) * | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
US7456184B2 (en) * | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
US7732451B2 (en) * | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
US7053223B2 (en) * | 2003-02-14 | 2006-05-30 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
US7227023B2 (en) | 2003-04-30 | 2007-06-05 | Wyeth | Quinoline 3-amino chroman derivatives |
US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
US7968548B2 (en) * | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
WO2006040178A1 (en) * | 2004-10-14 | 2006-04-20 | Abbott Gmbh & Co.Kg | Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
UY32442A (es) * | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
UA121206C2 (uk) | 2014-01-24 | 2020-04-27 | Турнінґ Поінт Терапьютикс, Інк. | Діарильні макроцикли як модулятори протеїнкіназ |
CN107735399B (zh) | 2015-07-02 | 2021-01-26 | 特普医药公司 | 作为蛋白质激酶的调节剂的手性二芳基大环 |
KR20180033194A (ko) | 2015-07-21 | 2018-04-02 | 티피 테라퓨틱스, 인크. | 키랄 디아릴 매크로사이클 및 이것의 용도 |
KR20190034225A (ko) | 2016-07-28 | 2019-04-01 | 티피 테라퓨틱스, 인크. | 거대환 키나제 억제제 |
TWI808958B (zh) | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
WO2018151240A1 (ja) * | 2017-02-17 | 2018-08-23 | 第一三共株式会社 | 3,6,7,8-テトラヒドロシクロペンタ[e]インドール化合物 |
MY201925A (en) | 2017-07-28 | 2024-03-23 | Turning Point Therapeutics Inc | Macrocyclic compounds and uses thereof |
WO2019126122A1 (en) * | 2017-12-19 | 2019-06-27 | Tp Therapeutics, Inc. | Macrocyclic kinase inhibitors and their use |
HRP20221502T1 (hr) * | 2017-12-19 | 2023-03-31 | Turning Point Therapeutics, Inc. | Makrociklički spojevi za liječenje bolesti |
TW202220965A (zh) * | 2020-08-06 | 2022-06-01 | 美商塔朵根公司 | 用於心理疾患或心理增強之2-胺基茚滿化合物 |
CN112724068A (zh) * | 2020-12-30 | 2021-04-30 | 蔡桂坡 | 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4060626A (en) * | 1972-01-26 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Indole-carboxylic carbon compounds and pharmaceutical compositions containing them |
DE2740836A1 (de) * | 1977-09-10 | 1979-03-22 | Troponwerke Gmbh & Co Kg | Anellierte indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US4110339A (en) * | 1977-11-25 | 1978-08-29 | Eli Lilly And Company | 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole |
CA1159459A (en) * | 1980-12-11 | 1983-12-27 | Andre A. Asselin | 6,7,8,9-tetrahydro-3h-benz¬e| indolamine derivatives |
US4510157A (en) * | 1982-12-27 | 1985-04-09 | Ayerst, Mckenna & Harrison, Inc. | 6,7,8,9-Tetrahydro-1H-benz(g)indol-8-amine derivatives |
US4470990A (en) * | 1983-03-14 | 1984-09-11 | Ayerst, Mckenna & Harrison Inc. | 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants |
FR2613364B1 (fr) * | 1987-04-01 | 1989-06-09 | Adir | Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
FR2613365B1 (fr) * | 1987-04-01 | 1989-07-28 | Adir | Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
DK0510068T3 (da) * | 1990-01-11 | 1999-10-25 | Upjohn Co | Nye 6,7,8,9-tetrahydro-3H-benz(e)indol-heterocycler med virkning på centralnervesystemet |
-
1994
- 1994-03-21 DK DK94911606T patent/DK0690843T3/da active
- 1994-03-21 ES ES94911606T patent/ES2149869T3/es not_active Expired - Lifetime
- 1994-03-21 EP EP94911606A patent/EP0690843B1/de not_active Expired - Lifetime
- 1994-03-21 AT AT94911606T patent/ATE195935T1/de not_active IP Right Cessation
- 1994-03-21 DE DE69425736T patent/DE69425736T2/de not_active Expired - Fee Related
- 1994-03-21 AU AU64086/94A patent/AU679053B2/en not_active Ceased
- 1994-03-21 US US08/522,290 patent/US5639778A/en not_active Expired - Fee Related
- 1994-03-21 PT PT94911606T patent/PT690843E/pt unknown
- 1994-03-21 NZ NZ263403A patent/NZ263403A/en not_active IP Right Cessation
- 1994-03-21 JP JP52118994A patent/JP3298885B2/ja not_active Expired - Fee Related
- 1994-03-21 WO PCT/US1994/002800 patent/WO1994021608A1/en active IP Right Grant
-
2000
- 2000-11-24 GR GR20000402612T patent/GR3034906T3/el not_active IP Right Cessation
-
2001
- 2001-08-30 LV LVP-01-129A patent/LV12792B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994021608A1 (en) | 1994-09-29 |
JPH08508251A (ja) | 1996-09-03 |
DK0690843T3 (da) | 2000-11-13 |
JP3298885B2 (ja) | 2002-07-08 |
EP0690843A1 (de) | 1996-01-10 |
ES2149869T3 (es) | 2000-11-16 |
US5639778A (en) | 1997-06-17 |
GR3034906T3 (en) | 2001-02-28 |
AU679053B2 (en) | 1997-06-19 |
NZ263403A (en) | 1996-10-28 |
PT690843E (pt) | 2001-01-31 |
LV12792A (en) | 2002-02-20 |
AU6408694A (en) | 1994-10-11 |
EP0690843B1 (de) | 2000-08-30 |
ATE195935T1 (de) | 2000-09-15 |
DE69425736T2 (de) | 2001-04-12 |
DE69425736D1 (de) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV12792B (en) | Formyl- or cyano- substituted indole derivatives having dopaminergic activity | |
ATE119522T1 (de) | Substituierte cyclohexanole mit zentraler nervensystemwirkung. | |
HU9601790D0 (en) | Diazabicyclic neurokinin antagonists | |
HUT70520A (en) | 1,3-substituted cycloalkenes and cycloalkanes | |
GR3019782T3 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
WO1992007832A3 (en) | Substituted piperazines as central nervous system agents | |
ATE131056T1 (de) | Verwendung von 2,3,4,5-tetrahydro-1h-3- benzazepinen bei der behandlung von neurologischen störungen. | |
ATE208196T1 (de) | Verwendung von lemellarin alkaloiden in therapeutischen verfahren | |
ZA909774B (en) | Substituted cyclohexenes as central nervous system agents | |
MX9702350A (es) | Derivados 2,7-sustituidos de octahidro-1h-pirido (1,2-a) pirazina. | |
BG103089A (en) | Indoline derivatives useful as 5-ht-2c-receptor antagonists | |
WO1996032944B1 (en) | Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor | |
DE3866719D1 (de) | Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie. | |
AR029331A1 (es) | Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa | |
ES8604843A1 (es) | Un metodo para la preparacion de un derivado de acetileno | |
ATE229953T1 (de) | Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems | |
IL104657A0 (en) | Benzazepine derivatives,their preparation and pharmaceutical compositions containing them | |
NO180635C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv tetracyklisk imidazolinforbindelse | |
CA2157586A1 (en) | Indoletetralins having dopaminergic activity | |
ES8506032A1 (es) | Un procedimiento para la preparacion de un derivado de ergolina |